When it comes to running a successful ELISA, there can be many common issues that must be addressed in order to obtain meaningful results. From our years of experience in producing and supplying ELISAs for a diverse range of targets, we’ve narrowed down four of the most common issues that can arise during your ELISA and have provided troubleshooting tips for each.

Whether it's at your home office, at the bench, or during your commute to work, putting on a podcast in the background can be an engaging and enriching way to help keep your mind stimulated. Here are 5 excellent science podcasts to help you get started on crafting your perfect workday playlist.

During these past few months, the push to discover effective treatments and vaccines against COVID-19 has largely overshadowed another vitally important aspect of drug development: drug pricing. Let’s take a look at a recent example from pharma giant Gilead, who recently announced the pricing for its promising COVID-19 treatment remdesivir.

In direct support of the fight against the novel coronavirus and the world's effort to understand more about the mechanisms of the COVID-19 disease, we're proud to announce the arrival of our SARS-CoV-2 Neutralizing Antibody.

Over these past few months, we here at ABclonal have been working diligently to continue supplying necessary reagents to researchers, clinicians, and companies worldwide to facilitate their efforts during the COVID-19 pandemic. In direct support of that goal, we’re proud to introduce our new, comprehensive line of SARS-CoV-2 ELISA kits.

On a bit of a lighter note this week, let’s take a dive into the origins of the beloved Guinea pig and their often overlooked role in the development of some major breakthroughs in the field of medical research.